USE OF CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR PREPARING MEDICINES DESIGNED TO FACILITATE SMOKING CESSATION
摘要
<p>The invention concerns the use of N-piperidino-5-(chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide to facilitate smoking cessation.</p>
